Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00984022 · ClinicalTrials.gov registry record · Phase 2
Aquacel Versus Iodoform Gauze for Filling Abscess Cavity Following Incision and Drainage
A Phase 2 study of Abscess and Cellulitis, sponsored by Valleywise Health.
- Completed
- Registry status
- Phase 2
- Development phase
- 92
- Enrollment target
- 1
- Study location
NCT00984022: Completed Phase 2 study of Abscess and Cellulitis, sponsored by Valleywise Health.
NCT00984022 is a Phase 2 study of Abscess and Cellulitis that has completed, run by Valleywise Health. The registered enrollment target is 92 participants, below the 383-participant average among 13 other Abscess trials with a reported enrollment target (76% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00984022, a Phase 2 study of Abscess and Cellulitis, has completed, sponsored by Valleywise Health.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 92 participants
- Enrollment target
- 1
- Study location
Study Summary
This study compares Aquacel against routine Iodoform packing for packing abscess cavities after incision and drainage. It is hypothesized that Aquacel will produce speedier healing of the abscess.
Primary Outcome
Participants were assessed to see whether or not the surface area of the abscess was reduced by at least 30%, and the number of such participants is reported.
Conditions Studied
Interventions
- DEVICE Type of dressing - Iodoform
- DEVICE Type of dressing - Aquacel
Study Locations (1)
Arizona
- Maricopa Integrated Health System - Phoenix
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 92 participants |
| Start Date | 2008-03 |
| Est. Completion | 2010-02-23 |
| Phase | Phase 2 |
What the finished NCT00984022 record still lists
NCT00984022 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 92 participants, a relatively small participant target, below the 383-participant average among 13 other Abscess trials with a reported enrollment target (76% lower).
The record links to 2 conditions, with Abscess appearing as the primary indexed condition, and to 2 interventions - of which Type of dressing - Iodoform is the first listed.
NCT00984022 reports a single indexed study location in Arizona.
Frequently Asked Questions
What is clinical trial NCT00984022 about?
NCT00984022 is a clinical study titled "Aquacel Versus Iodoform Gauze for Filling Abscess Cavity Following Incision and Drainage". This study compares Aquacel against routine Iodoform packing for packing abscess cavities after incision and drainage. It is hypothesized that Aquacel will produce speedier healing of the abscess.
What is the current status of trial NCT00984022?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 92 participants. The study started on 2008-03. Estimated completion is 2010-02-23.
What conditions does trial NCT00984022 study?
This clinical trial studies the following conditions: Abscess, Cellulitis.
What interventions are being tested in trial NCT00984022?
The interventions under investigation include: Type of dressing - Iodoform (DEVICE), Type of dressing - Aquacel (DEVICE).
Who is sponsoring clinical trial NCT00984022?
This trial is sponsored by Valleywise Health, which has 9 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00984022 being conducted?
This trial has 1 study location across Arizona. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Abscess
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00984022's enrollment target sits among peer trials
92 9th of 13 higher than 5 of 13 other Abscess trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Abscess trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Phase 2 Trial of TD 6424 (Telavancin) Versus Standard Therapy for Complicated Gram Positive Skin and Skin Structure Infections (Gram Positive cSSSI)
COMPLETED · Phase 2
-
Ketamine as a Supplement to Local Anesthesia for Minor Procedures
RECRUITING · Phase 4
-
Efficacy of Intranasal Fentanyl at Reducing Pain During Abscess Incision and Drainage (I&D) in Children
COMPLETED · Phase 3
-
Adjunctive Nitrous Oxide During Emergency Department Propofol Sedation in Adults
COMPLETED · NA
-
Decreasing Antibiotic Duration for Skin and Soft Tissue Infection Using Behavioral Economics in Primary Care
COMPLETED · NA
-
Evaluation of 3 Versus 10 Days of Antibiotics in Skin Abscesses After Surgical Drainage
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03184545 · 92 participants · Phase 3
Comparing the Outcome of Electrical Stimulation and Physical Therapy in Patellofemoral Pain Syndrome
- NCT04172532 · 92 participants · Phase 1
Testing the Addition of a New Anti-cancer Drug, M3814 (Peposertib), to the Usual Radiotherapy in Patients With Locally Advanced Pancreatic Cancer
- NCT04508088 · 92 participants
Skeletal Health and Bone Marrow Composition in Newly Diagnosed Adolescents With Crohn Disease
- NCT04840602 · 92 participants · Phase 2
Testing the Combination of Venetoclax and Rituximab, in Comparison to the Usual Treatment (Ibrutinib Plus Rituximab or Zanubrutinib Alone) for Waldenstrom's Macroglobulinemia/Lymphoplasmacytic Lymphoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia